SAB Biotherapeutics (SABSW) Q2 2024 Earnings

20MayConfirmed
Mar 21
Jun 21
Sep 21
Q2 2024
-0.96
-0.64
-0.32
0

Details

Expected EPS
-0.96
Actual EPS
-0.54
Surprise EPS
0.42
Surprise Percent
+43.75%

Description

SAB Biotherapeutics (SABSW) has reported earnings of -0.54 per share for Q2 2024.

0 Comments

Share your thoughts